PureTech Health (PRTC) Invested Capital (2019 - 2022)
Historic Invested Capital for PureTech Health (PRTC) over the last 6 years, with Q4 2024 value amounting to $407.9 million.
- PureTech Health's Invested Capital fell 1941.38% to $407.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $407.9 million, marking a year-over-year decrease of 1941.38%. This contributed to the annual value of $407.9 million for FY2024, which is 1941.38% down from last year.
- As of Q4 2024, PureTech Health's Invested Capital stood at $407.9 million, which was down 1941.38% from $506.2 million recorded in Q4 2023.
- Over the past 5 years, PureTech Health's Invested Capital peaked at $668.4 million during Q4 2020, and registered a low of $407.9 million during Q4 2024.
- Moreover, its 5-year median value for Invested Capital was $599.3 million (2021), whereas its average is $565.4 million.
- Its Invested Capital has fluctuated over the past 5 years, first skyrocketed by 768.57% in 2022, then tumbled by 2155.76% in 2023.
- Quarter analysis of 5 years shows PureTech Health's Invested Capital stood at $668.4 million in 2020, then fell by 10.34% to $599.3 million in 2021, then grew by 7.69% to $645.3 million in 2022, then dropped by 21.56% to $506.2 million in 2023, then fell by 19.41% to $407.9 million in 2024.
- Its Invested Capital stands at $407.9 million for Q4 2024, versus $506.2 million for Q4 2023 and $645.3 million for Q4 2022.